EQUILLIUM, INC. Public Float
EQUILLIUM, INC. (EQ) had Public Float of $7.10 million as of 2025-06-30, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-25
- 2025-06-30: Entity Public Float $7.10M.
- 2024-06-28: Entity Public Float $15.40M.
- 2023-06-30: Entity Public Float $16.00M.
- 2022-06-30: Entity Public Float $43.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $7.10M 10-K · filed 2026-03-25 |
| 2024-06-28 | $15.40M 10-K · filed 2025-03-27 |
| 2023-06-30 | $16.00M 10-K · filed 2024-03-25 |
| 2022-06-30 | $43.10M 10-K · filed 2023-03-23 |
| 2021-06-30 | $95.30M 10-K · filed 2022-03-23 |
| 2020-06-30 | $18.80M 10-K · filed 2021-03-24 |
| 2019-06-28 | $33.70M 10-K · filed 2020-03-26 |
| 2018-06-30 | $0.00 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |